FSRJX
Price
$10.60
Change
+$0.11 (+1.05%)
Updated
Sep 3 closing price
Net Assets
3.2B
VGSNX
Price
$21.21
Change
+$0.21 (+1.00%)
Updated
Sep 3 closing price
Net Assets
73.11B
Interact to see
Advertisement

FSRJX vs VGSNX

FSRJX vs VGSNX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 73.1B vs. FSRJX (3.2B). VGSNX pays higher dividends than FSRJX: VGSNX (3.62) vs FSRJX (2.14). FSRJX was incepted earlier than VGSNX: FSRJX (2 years) vs VGSNX (23 years). FSRJX (0.56) is less costly to investors than VGSNX (0.11). FSRJX is a more actively managed with annual turnover of: 15.00 vs. VGSNX (7.00). FSRJX has a lower initial minimum investment than VGSNX: FSRJX (0) vs VGSNX (5000000). FSRJX annual gain was more profitable for investors over the last year : 12.33 vs. VGSNX (9.53).
FSRJXVGSNXFSRJX / VGSNX
Total Expense Ratio0.560.11509%
Annual Report Gross Expense Ratio0.560.11509%
Fund Existence2 years23 years-
Gain YTD12.19510.274119%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.2B73.1B4%
Annual Yield % from dividends2.143.6259%
Returns for 1 year12.339.53129%
Returns for 3 yearsN/A30.69-
Returns for 5 yearsN/A4.61-
Returns for 10 yearsN/A52.66-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATHR3.130.12
+3.99%
Aether Holdings Inc
EFSCP18.360.13
+0.71%
Enterprise Financial Services Corp
SYRE87.250.20
+0.23%
Spyre Therapeutics
VLOS10.69N/A
N/A
Velos Acquisition I Corp
PAHC38.58-1.34
-3.36%
Phibro Animal Health Corp